Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Journal of Experimental Therapeutics & Oncology|November 21, 2002
Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transductionMuneyuki Masuda, Masumi Suzui, Jin T E Lim, et al.
Nihon Jibiinkoka Gakkai Kaiho|October 2, 2004
[Treatment of hypopharyngeal carcinomas--an institutional analysis of the results of FAR radiochemotherapy, radical resection, and free jejunum flap reconstruction and the indication of neck dissection]Yuichiro Kuratomi, Tomoya Yamamoto, Yoshihiko Kumamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cellsJin T E Lim, Andrew K Joe, Masumi Suzui, et al.
Nihon Jibiinkoka Gakkai Kaiho|July 31, 2004
[Laminin gamma2 chain expression in squamous cell carcinomas of the tongue and its clinical relevance]Yuichiro Kuratomi, Mayuko Kumamoto, Ryuji Yasumatsu, et al.
Cancer Research|July 19, 2002
Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1Masumi Suzui, Muneyuki Masuda, Jin T E Lim, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 26, 2013
A minimally invasive method to prevent postlaryngectomy major pharyngocutaneous fistula using infrahyoid myofascial flapHideki Kadota, Junichi Fukushima, Kenichi Kamizono, et al.
Clinical Case Reports|September 29, 2021
Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?Muneyuki Masuda, Ryozaburo Nagata, Hirotaka Hara, et al.
Cancers|July 27, 2024
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active DiscontinuationMioko Matsuo, Muneyuki Masuda, Moriyasu Yamauchi, et al.
Head & Neck|July 12, 2002
"FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinomaYoshihiko Kumamoto, Muneyuki Masuda, Yuichiro Kuratomi, et al.
Oral Oncology|August 8, 2025
Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancerTakahiro Hongo, Yusuke Hirano, Yu Tarutani, et al.
Pageof 10